Quality Investor

Brown-Forman Corporation

Rank #223Value

BF-B · NYSE · Consumer Defensive

Brown-Forman Corporation (BF-B) — Rank #223 by gross profitability (GP/assets 0.30) · ROE 18.0% · Piotroski F-Score 7 / 9.

As-of 2026-09-15 · CIK 0000014693 · all metrics point-in-time as of the filing date.

About

Brown-Forman Corporation, together with its subsidiaries, manufactures, distills, bottles, imports, exports, markets, and sells a variety of alcohol beverages.

Show more

The company provides spirits, wines, whiskey spirits, whiskey-based flavored liqueurs, ready-to-drink cocktails, ready-to-pour products, vodkas, tequilas, gin, brandy, rum, bourbons, and liqueurs. The company offers its products primarily under the Jack Daniel's, Woodford Reserve, Old Forester, Gentleman Jack, Herradura, el Jimador, Fords Gin, The Glendronach, Chambord, Coopers' Craft, Diplomático, Benriach, Glenglassaugh, and Slane brands. It is also involved in the sale of used barrels, and bulk whiskey and wine; and provision of contract bottling services. The company serves retail customers and consumers through distributors and state governments; and retailers, wholesalers, and provincial governments directly. It operates in the United States, Germany, Australia, the United Kingdom, Canada, Spain, France, Mexico, Poland, Brazil, Türkiye, and internationally.

Brown-Forman Corporation was founded in 1870 and is headquartered in Louisville, Kentucky.

Industry
Beverages - Wineries & Distilleries
Sector
Consumer Defensive
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
April 30

Price History

BF-B-58.5% · -16.1% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and dividend yield are the primary valuation lenses for mature businesses.

Market Cap

$11.99B

P/E (annual)

17.1

P/S (annual)

3.1

P/B

3.0

P/OCF (annual)

12.0

Shareholder Yield

4.9%

Employees

4,900

Industry

Beverages - Wineries & Distilleries

Exchange

NYSE

Signal Flags

2 green1 yellow2 red
Revenue growth acceleratingGrowth rate increasing year over year
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 1-quarter streak
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why
Revenue declining YoYRevenue contracted year over year
Operating margin decliningOperating margin lower than prior year

Quality Profile

Profitability

1/1 pass
GP / assets
0.30
Return on equity
18.0%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.97
Current ratio
3.26×
Net cash
-$2.14B

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
0.8%

Growth

1/2 pass
Revenue growth
-1.2%
Piotroski F-Score
7 / 9
Share dilution
-1.3%

Terry Smith quality gate

Passes 3/5 Terry Smith thresholds

What Growth Is Priced In

Implied revenue growth (10Y)

2.5%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Buyback tailwind: -1.3% — per-share value needs a total required return of 1.2% once share-count change is priced in.

vs. own 6-year median revenue growth: 0.9%

priced above its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

-1.5%

r = 10% (base)

2.5%

r = 12%

5.9%

Net debt / market cap: 17.6%

Base FCF: $893M3Y mean FCF: $581M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

17.7xCheap
14.4xmed 38.1x41.8x

P / S

Price / revenue per share

3.2xCheap
3.1xmed 8.2x10.3x

P / B

Price / book value per share

3.1xCheap
3.1xmed 12.5x21.1x

P / GP

Price / gross profit per share

5.3xCheap
5.3xmed 12.7x17.0x

P / FCF

Price / free cash flow per share

14.1xCheap
14.1xmed 48.4x68.8x

Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).

Profitability

Gross profitability (GP / assets)

0.30

Primary signal (Novy-Marx).

4th of 18 SIC 20 peers

Return on equity

18.0%

Gross margin

60.5%

1st of 18 SIC 20 peers

Revenue growth (YoY)

-1.2%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2023202420252026
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

-2.4%

Revenue CAGR (5Y)

2.6%

Earnings CAGR (3Y)

-3.0%

FCF CAGR (3Y)

25.0%

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.97

14th of 18 SIC 20 peers (best = lowest)

Current ratio

3.26×

8th of 18 SIC 20 peers

Quick ratio

0.93×

Net cash

-$2.14B

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$893.00M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

0.25

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.8%

Stock-based comp intensity.

Dividend safety

Composite score

3.2 / 5

Good
Payout ratio
59.7%3/5 Good
FCF coverage
2.09×4/5 Strong
Dividend growth streak
3 yr2/5 Fair
Balance-sheet health
D/E 0.97 · IC 9.72×4/5 Strong

Piotroski F-Score

F-Score

7 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20212026
Value
Capital Return